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Abstract
To ensure the health of mothers and children, prevention of mother-to-child HIV transmis-
sion (PMTCT) programs test women for HIV, engage HIV-positive women in care, and pro-
mote recommended breastfeeding practices. Under Malawi’s Option B+ PMTCT program,
~20% of women are lost-to-follow-up (LTFU) and little is known about their breastfeeding
practices. The purpose of this study is to describe facilitators and barriers to Option B+ par-
ticipation and how participation influences breastfeeding duration. We conducted in-depth
interviews with HIV-positive women in Option B+ (n = 32) or LTFU from Option B+ (n = 32).
They were recruited from four government clinics in Lilongwe District and had a child aged
0–23 months. Women in Option B+ had better disclosure experiences and more social sup-
port than LTFU women. The most common reasons for LTFU were fear of HIV disclosure,
anticipated or experienced stigma, and insufficient social support. Other reasons included:
non-acceptance of HIV status, antiretroviral therapy (ART) side effects, lack of funds for
transport, and negative experiences with clinic staff. Worries about possible transmission,
even while on ART, influenced timing of weaning for some women in Option B+. Despite
their knowledge of the risk of HIV transmission to the child, most LTFU women continued
to breastfeed after stopping ART because they considered breastmilk to be an important
source of nutrients for the child. Given that HIV-positive Malawian women LTFU from
Option B+ breastfeed in the absence of ART, efforts are needed to use evidence-based
strategies to address the barriers to Option B+ participation and avert preventable transmis-
sion through breastmilk.
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Introduction
Antiretroviral therapy (ART) and optimal infant feeding practices are the two main strategies
recommended by the World Health Organization (WHO) for limiting HIV transmission from
mother to child and improving the HIV-free survival of exposed infants and young children
[1,2]. Prevention of mother-to-child transmission (PMTCT) programs in low- and middle-
income countries with high HIV prevalence typically implement these guidelines through
same-day HIV testing and treatment initiation for pregnant or breastfeeding women and
through group or individual infant feeding counseling. Option B+ is currently the most widely
used PMTCT strategy [3]. It offers lifelong ART regardless of women’s immunologic or clini-
cal disease stage [2]. At the time of this study, WHO recommended that HIV-positive women
should exclusively breastfeed their infants until six months and continue breastfeeding until
12 months [1]. Malawi modified the guidelines to extend continued breastfeeding to 24
months [4]; the same extended period of breastfeeding was recently adopted under the
updated WHO HIV and infant feeding guidelines [5].
Option B+ has increased PMTCT participation and ART coverage among pregnant HIV-
positive women in Malawi [6–8]. However, approximately 20% of Malawian women who are
tested and enrolled in Option B+ are lost to follow-up (LTFU), with more than half of these
stopping ART [9]. Loss to follow-up occurs most frequently during the first three months after
women start the program and among women with high CD4 counts or those who enter
PMTCT and initiate ART while breastfeeding [10,11]. Studies of barriers to PMTCT participa-
tion found that some of the common reasons women dropped out were fears of involuntary
HIV disclosure; stigma from family and community members; negative interactions with
health staff; lack of support from husbands; and difficulties accessing services [11–17].
While these studies provide useful information for improving PMTCT programs, there are
some important gaps. Few studies of challenges to PMTCT participation were conducted
within the context of Option B+ [9,18–20] and only two of these collected qualitative data on
the reasons women drop out of the program [18,20]. There are only a few studies that focused
on challenges to PMTCT participation up to 18–24 months postpartum [17,21]. In addition,
little is known about how ART use or the decision to stop using ART influences breastfeeding
practices or, conversely, whether the decision or perceived need to breastfeed contributes to
ART use. The aims of this study were to identify facilitators and barriers to Option B+ partici-
pation and to document the duration of breastfeeding among HIV-positive women with chil-
dren 0–23 months of age who were participating in or had been LTFU from Option B+.
Methods
Study setting and sample
We conducted qualitative in-depth interviews with 64 HIV-positive women from July
2014-January 2015. Half of them were participating in Option B+ and the other half were
LTFU from the Option B+ program. Women were enrolled in the study if they were 18
years of age, lived in the catchment areas of four government clinics (two urban, two rural) in
Lilongwe District, Malawi, and had a child 0–23 months of age. Women who were LTFU were
recruited if they conformed to the Malawi Ministry of Health’s definition (i.e., failure to attend
the clinic for>60 days since their last scheduled PMTCT visit). We purposively sampled equal
numbers of women with children in four age groups (0–5, 6–11, 12–17, and 18–23 months) to
ensure that we collected information about feeding practices throughout the period when
women are usually enrolled in PMTCT in Malawi. We planned our sample sizes in advance so
that we would have eight women with a child in each age group among women in PMTCT
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and among LTFU women. Our sub-group sample sizes exceeded the minimum of six inter-
views needed to achieve saturation [22], and we found during the analysis that we had attained
saturation.
Research assistants responsible for data collection were Malawian university graduates
trained on qualitative interviewing techniques and the specifications of this study for five days.
They recruited PMTCT participants as they arrived at the clinic for their regular PMTCT visits
and checked the women for eligibility. Research assistants approached and recruited women
until they reached the target enrollment (e.g., two women per child age group per clinic). Dif-
ferent strategies were employed in the four clinics to recruit LTFU women for the study.
Health workers used patient lists and contacted LTFU women starting from those who were
most recently lost from the program. In the largest, urban clinic, health care workers contacted
LTFU women by phone to schedule interviews. In the other clinics, cell phone numbers were
used when available, but most often a health care worker or health surveillance assistant went
to the woman’s home to schedule the interview appointment. Interviews with women in
PMTCT took place at the clinics, whereas interviews with LTFU women took place either in
the women’s homes or at a clinic.
Ethical issues
For interviews with PMTCT participants and LTFU women at clinics, research assistants con-
ducted them in a private room or an area away from other patients. For interviews at LTFU
women’s homes, research assistants used cover stories so that they did not reveal the topic of
the interview if family or community members asked questions about their presence. They
stopped the interview temporarily if anyone entered the room while the interview was
underway.
Research assistants obtained written or thumb-printed informed consent from all partici-
pants after reading the Chichewa consent aloud and answering participants’ questions. The
Institutional Review Board at the University of North Carolina (#13–3615) and the Malawi
Ministry of Health’s National Health Sciences Research Committee (NHSRC #1231) provided
ethical approval for the study.
Data collection
The in-depth interviews were conducted by four Malawian research assistants. Interview
guides for PMTCT participants and LTFU women included open-ended questions followed
by probes to help interviewers collect more detailed information on women’s experiences with
PMTCT services (facilitators and barriers), HIV disclosure experiences, support for PMTCT
participation from family or friends, breastfeeding practices, and use of ART. For LTFU
women, the guides also included questions on reasons for and timing of stopping PMTCT par-
ticipation. The guides were prepared in English and translated into Chichewa. They were
piloted and the translations were adjusted to improve clarity before beginning data collection.
Interviews were digitally recorded and lasted 20–45 minutes. They were transcribed verbatim
in Chichewa then translated into English.
Data analysis
We entered in-depth interview transcripts into Dedoose (Version 5.0.11, SocioCultural Con-
sultants LLC) and analyzed them using thematic analysis [23]. The coding team included the
first author and three students at the University of North Carolina who were trained in qualita-
tive analysis techniques for this project. The coding team met weekly to discuss the codes and
make changes to the codebook to capture new ideas that emerged from the data. We initially
Option B+ participation and breastfeeding duration
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used deductive codes based on the question guides and then conducted a second round of cod-
ing using inductive codes that emerged from the data during the deductive coding process. To
ensure consistency across coders, the first author independently coded ten percent of the inter-
views to compare with students’ coding. Discrepancies were discussed by the team and a con-
sensus was reached on the final code definitions and application. We entered coded data into
data matrices to facilitate identification of themes, comparisons across groups, and selection of
illustrative quotes [24].
Trustworthiness of the findings
We took several steps to ensure the trustworthiness of our findings [25]. The research team
was comprised of Malawians and Americans who have long-term research experience in
Malawi. The study from which the data were drawn included observations and interviews with
health workers, which could be used to triangulate the findings [26]. We selected different
types of clinics and use purposive sampling to improve transferability of the results to other
settings [27]. We improved the dependability of repeating the findings by checking the consis-
tency of our coding and making sure we achieved data saturation. Further, our findings align
with other research in Malawi [12,13,18,21] and have been corroborated by subsequent
research [28].
Results
Participant characteristics and breastfeeding practices
The characteristics of enrolled PMTCT participants and LTFU women were generally similar.
On average women in the study were 27 years of age, had six years of education, had given
birth to three children, and owned two household items out of a list of 10 (including electricity,
paraffin lamp, radio, television, phone, mattress, table and chairs, sofa, and refrigerator).
About one-fifth of PMTCT participants and LTFU women had been diagnosed with HIV > 2
years ago, either during a previous pregnancy or as a result of illness. Slightly more LTFU
women than participants were not married and reported household food insecurity, which
was present among >80% of the women in both groups.
Among LTFU women, three participants did not admit they had stopped participating, two
never started taking ART, six stopped taking ART during pregnancy, and one stopped at the
birth of the child. Other LTFU women stopped taking ART when the child was 0–5 months
(n = 10), 6–11 months (n = 7), or 12 months (n = 3).
Patterns of breastfeeding duration were similar among PMTCT participants and LTFU
women. Of the 32 PMTCT participants in our sample, 27 were still breastfeeding at the time
of the interview. Five PMTCT participants decided to wean early, and four of the participants
who were still breastfeeding planned to wean the child before 24 months. Those participants
who weaned early or planned to wean early had a variety of reasons, but the most common
was that they were worried about HIV transmission even though they were on ART. For
example, PMTCT participant #28 said, “I thought of stopping to breastfeed my child [at 9
months] because I can suddenly transmit the virus to him.” Out of 32 LTFU woman, 24 were
still breastfeeding at the time of the interview, although they were no longer taking ART.
Eight LTFU woman weaned the child early and half of these had either ceased breastfeeding
prior to or concurrently with stopping use of ART. The number of months LTFU women
breastfed without ART coverage ranged from 0 to 11 and averaged four months at the time
of the interviews.
Option B+ participation and breastfeeding duration
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Facilitators and barriers to Option B+ participation
Key facilitators to Option B+ participation were knowledge of the health benefits of ART,
good HIV disclosure experiences, support from family members, and good experiences with
health workers. Fear of HIV transmission through breastmilk did not motivate LTFU women
to return to care. The most common barriers to participating in Option B+ were fear of HIV
disclosure, fear of HIV stigma, lack of support from family, and issues related to travel and
accessing ART. Other barriers included: lack of self-acceptance of HIV status, ART side effects,
and negative experiences with health workers. Based on these themes, we grouped facilitators
and barriers to Option B+ participation into three categories: individual, family, and health
facility.
Individual. The most frequent individual issues related to Option B+ participation were
knowledge of ART benefits, breastfeeding decision-making, lack of self-acceptance of HIV sta-
tus, and ART side effects. For women in PMTCT, individual women’s knowledge of the bene-
fits of taking ART for their own health and for preventing transmission to their children
through breastmilk was an important facilitator of PMTCT participation. For example, one
PMTCT participant (#27) explained, “I feel good because I protect my baby from getting the
virus. If I don’t take the drugs and breastfeed my child, it is obvious the virus will be transmitted.”
Most PMTCT participants felt comfortable with breastfeeding while on ART and wanted to
continue breastfeeding until 24 months. PMTCT participant #26 stated, “I will wean at 24
months because the baby will be grown and will have some knowledge about eating food. Also, we
were told here [at the clinic] that we can breastfeed up to 24 months.”
LTFU women who continued breastfeeding knew that they could transmit HIV to the
infant through breast milk and many of them were worried about this. For example, LTFU
woman #59 explained, “When I stopped taking the drugs, I was not okay with it. I had worries
that as I am continuing to breastfeed my child I will transmit the virus to him.” Despite their
worries, fear of HIV transmission through breastmilk did not prompt LTFU women to return
to care and many of those who were still breastfeeding planned to continue until the child was
24 months of age. They explained that they did this because the children were still young and
needed breastmilk to be healthy. LTFU woman #33 described her reasoning for continued
breastfeeding in the absence of ART, “I was breastfeeding him without any protection. But
because of the kind of food [our family has available], it was difficult for me to wean him as I
thought that the child might become unhealthy.”
Other individual issues that were barriers to PMTCT participation for some LTFU women
were unwillingness to start taking ART because the woman had not accepted her HIV status
and ART side effects. Each of these issues were mentioned by a few of the LTFU women in our
sample. The PMTCT strategy to test pregnant and breastfeeding women for HIV and start
them on ART immediately made some women feel like they did not have time to adjust to the
information about their status. For example, LTFU woman #62 explained, “Yes, they gave me
[ART drugs], but at that time I was not ready to start taking them, so I just kept them.” Many
women in our sample said they experienced ART side effects, especially when they first started
taking the drugs. One PMTCT participant (#1) described her experiences with ART, “My head
used to feel dizzy at first when I took [the drugs], but now it’s all fine. . .It just happened that
everything started to be okay from nowhere, but during the first days I was not okay.” For a few
LTFU women, the side effects were prolonged or so severe that they decided to stop taking
ART. LTFU woman #52 had persistent side effects. She explained, “I used to take the drugs and
when I took them I felt dizzy. I could not work properly, so I stopped taking them.”
Family. Family and social issues that facilitated or impeded PMTCT participation cen-
tered on the interrelated issues of HIV disclosure, HIV stigma, social support, and marital
Option B+ participation and breastfeeding duration
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relationships. All PMTCT participants had disclosed their HIV status, whereas four LTFU
women had not disclosed to anyone. More PMTCT participants (n = 27) than LTFU women
(n = 19) had disclosed their HIV status to their husbands, and more of them also disclosed to
their mothers, siblings, other relatives, and friends or neighbors. PMTCT participants had
fewer negative disclosure experiences than LTFU women. Twenty husbands of PMTCT partic-
ipants reacted positively when their wives disclosed their HIV status, two were neutral, and
three reacted negatively.
In contrast, LTFU women reported that 11 husbands accepted the news of their wife’s HIV
status, none were neutral, and nine reacted negatively.
Husbands’ and other relatives’ initial reactions and subsequent actions in relation to
women’s HIV status seemed to play an important role in terms of social support for women
to participate in PMTCT. Many PMTCT participants and some LTFU women received posi-
tive responses when they disclosed to family members. For example, a PMTCT participant
explained,
“They [my husband and sister] were fine with it and they have been encouraging me since [I
disclosed]. . .They encourage me to accept [my HIV status] as that is the way things are and [I
should] never be worried. So, I find encouragement from these people.”
PMTCT participant #6
Husbands and other family members often supported women’s participation in PMTCT
by reminding them to take their ART or to go to the clinic to collect the drugs. One woman
explained that her husband helps her as follows:
“He encourages and asks me at bedtime if I have taken the drugs, since we are given a specific
time to take the drugs. If I haven’t, he goes and gets the drug and water and gives it to me.”
PMTCT participant #15
Husbands of women in PMTCT may have been more supportive than those of LTFU
women because all HIV-positive husbands of PMTCT women were taking ART (13/13),
whereas less than half of HIV-positive husbands of LTFU women were on treatment (5/12).
When both members of the couple were HIV-positive and on treatment, they could support
each other to take their ART regularly.
When PMTCT participants did not receive encouragement from their husbands or if they
did not currently have a partner, they were encouraged or supported by other relatives or
friends. A married PMTCT participant (#14) explained, “When I disclosed to my husband that
I am HIV positive, he ran away. I disclosed to my grandparents, who said I should move and stay
with them.” Another PMTCT participant who was widowed said,
“At first I disclosed at home to my elder sister then I managed to disclose to my friends, the
ones I chat with. . . These people they just encouraged me that I should continue taking the
drugs the way they have been prescribed at the hospital.”
PMTCT participant #26
In contrast, many of the LTFU women were not in supportive environments and their hus-
bands’ reactions made it difficult for them to stay on treatment. Their husbands tended to
blame them for contracting the virus and stigmatized them. The following quote illustrates the
type of negative response and stigmatizing reaction from some husbands when their wives dis-
closed their HIV status:
Option B+ participation and breastfeeding duration
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“When I came back from the hospital, my husband asked me how I was. I told him that I was
diagnosed with the virus and then he changed. He started stigmatizing me. . . He started going
to bars and he would come home in the morning after spending the night there and sometimes
he would not come home. In some cases, he would not be at home for a week or a month. . . He
did not receive the news well and was very angry with me.”
LTFU woman #48
Some LTFU women were so worried about their husbands’, relatives’, or friends’ responses
to their HIV status that they either delayed disclosing or did not disclose at all. LTFU woman
#33 was worried about the consequences of disclosure on her marriage, but had an unexpect-
edly positive response when her husband discovered her ART.
“It was really a problem, because when I was given the results of my blood test here at the hos-
pital it was very difficult for me to tell my husband, since he was not an understanding man.
So, I kept quiet for months without explaining anything to him. . . By grace, he found the
drugs [ART]. That was when he asked me as to what I was doing with the drugs and I told
him that I had received the drugs from the hospital. . .as I have been found with the virus.
Then he said, ‘Why were you not telling me? I am ready to accept anything if things are like
this. I might be on the side of going for testing, too, so you were wrong [to hide]. You could
have just explained.’ And I saw that as a response from God since the thing that was causing
worry to me was what would happen if he finds out. Maybe my marriage would end.”
LTFU woman #33
Some women who did not disclose to their husbands were justified in their fear of disclo-
sure. For LTFU woman #42, her husband’s discovery of her drugs resulted in physical violence.
She explained, “My husband found the drugs and he asked me about them. I tried to explain, but
we ended up fighting. Look around my neck [showing interviewer scars on her neck].” She ulti-
mately left the PMTCT program because of the fights she had with her husband.
Non-disclosure was often related to fear of HIV stigma and made it difficult for women to
collect their ART from the clinic or hide taking ART. The following quotes are typical of the
interconnectedness of HIV stigma and disclosure and how this impacted LTFU women’s ART
use:
“My husband and the people from the community where I live, if they see me going to get ART,
since I haven’t revealed [my HIV status] to them, they will discriminate against me and say
bad things about me.”
LTFU woman #36
“I was away from home. I went to my mother-in-law’s place, so I thought it was not wise for
me to get my drugs [from the health center] because I did not disclose my HIV status to her.”
LTFU woman #35
Several LTFU women described unstable marital relationships that influenced their
PMTCT participation. The following two women explained how they started taking ART, but
then stopped due to changes in their relationship with their husbands.
“I was taking [ART] before, but then I had an argument with my husband, so I went to my
home village and I stopped. It’s been four months since I took them.”
LTFU woman #37
Option B+ participation and breastfeeding duration
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“I came to the hospital for HIV testing and I was found positive, so I started receiving ART. I
received the drugs for only one month. Then my husband left me and married another
woman, so I stopped taking the drugs and coming here to collect the drugs all together.”
LTFU woman #44
Health facility. The main health facility facilitators and barriers to PMTCT participation
were the women’s interactions with health workers and the amount of time they spent at the
clinic. Most respondents–both women in PMTCT and LTFU women–had positive or neutral
experiences with the health workers who provide PMTCT services in the study clinics. For
example, one respondent stated,
“They [the health workers] were treating us so nicely by greeting us, giving us the drugs, and
encouraging us that taking ART is not the end of our lives, but the beginning of another chap-
ter in life.”
LTFU woman #42
Among PMTCT participants, none had negative experiences with health workers, but two
of them were worried about the length of time they spent at the clinic during PMTCT visits.
One explained what happens at the clinic,
“When we get here the health workers are very slow in delivering their services. They don't
respect the fact that we have small children. They don't pay attention to us until lunch time
and then they leave for lunch without helping us.”
PMTCT participant #9
One-quarter of the LTFU women described negative interactions with health workers. One
woman stopped participating in PMTCT because a health worker disclosed her HIV status in
front of other patients. She explained,
“The health workers did not speak well to me. They asked me in the presence of other women
at the under-five clinic, ‘Have you collected your ART?’ This made me mad as I felt like I was
being embarrassed in front of other people.”
LTFU woman #36
For a few other women, a negative or harsh tone by health workers in the PMTCT program,
especially if they missed a clinic visit, was a barrier to participation. For example, LTFU
woman #33 stated, “I skipped a certain visit [to the hospital], as I had gone somewhere. When I
came back, I met the doctor and the way he spoke to me, I left again. . . I decided to just quit.” Sev-
eral LTFU women in our sample talked about their fear of being scolded by health workers if
they went back to the clinic to restart PMTCT.
Travel and transport were the most frequent access issues related to PMTCT participation.
Many LTFU women in our sample stopped taking ART because they moved or traveled to
visit or help relatives in another part of Malawi or in Mozambique. Some could not access
ART at a clinic near where they were visiting because they did not have a transfer letter and
others (as noted in one of the quotes above) were afraid to access ART when staying with peo-
ple who did not know their HIV status. One woman explained,
“I went to live with my mother. Unfortunately, I finished the drugs I received, but I wasn’t
allowed to receive drugs from a different hospital because they were demanding a referral letter
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and health passport book, which I forgot.”
LTFU woman #56
Another woman (LTFU #49) stated, “I took [ART] for six years. I stopped because I went to
Mozambique for some weeks. The drugs I carried got finished.”
For a few PMTCT participants and LTFU women finding money for transport to the clinic
to attend PMTCT visits was problematic. Five LTFU women cited transport as one of the rea-
sons they stopped participating in Option B+. One of them explained,
“[My husband] said it was a good thing that I know my HIV status. He was not unhappy,
because if he was, then I would not be coming to the hospital. But I stopped because I had
transport problems.”
LTFU woman #57
A few LTFU women who had transport issues also faced multiple problems simultaneously
and simply could not overcome them in order to stay in the PMTCT program. One of these
women described her situation as follows:
“I was in deep trouble. I had a job and I was laid off. Also, my child got sick while that was
happening and I was evicted from my house. I didn’t have the transport to travel from here to
[the clinic] and from [the clinic] to my house.”
LTFU woman #63
Women such as this one lack a social safety net or support from their family to see them
through a difficult time and facilitate continued PMTCT participation.
Discussion
The facilitators and barriers to PMTCT participation described in this study are similar to
those reported in other studies of PMTCT in sub-Saharan Africa in settings with Option B
+ and under other PMTCT options [9,11–20,29–33]. Our findings are consistent with studies
reporting that knowledge of the health benefits of ART is an important facilitator of women’s
PMTCT participation [18,29–31]. Like other research, this study found that fear of HIV disclo-
sure, fear of HIV stigma, and lack of social support were some of the most common barriers to
PMTCT participation [12–14,16,18–20,29,31,32]. Although cost of transport to the clinic,
ART side effects, and negative treatment by health workers were also mentioned as barriers,
each of these issues impacted only a few women and they were not the main barrier for most
LTFU women in our sample, as opposed to other studies [9,12,16,18–20,29,32–34].
This study adds to the literature by comparing experiences of PMTCT participants and
LTFU women. Through these comparisons, we found that positive disclosure experiences and
support from family members, whether from husbands or others, are key to helping women
overcome barriers to PMTCT participation. Women who had not disclosed their HIV status
to members of their household had trouble hiding daily use of ART because they feared inad-
vertent disclosure and the resulting stigma and other negative consequences, such as divorce,
which is commonly associated with PMTCT in some parts of Malawi [35]. We also showed
that disclosure, stigma, and lack of social support remain barriers to Option B+ participation
at all stages of the postpartum period, up to 24 months. These barriers are interrelated and
woven into some of the other reasons for stopping PMTCT participation. For example, when
women’s HIV status was disclosed by health staff in a public space during a health facility visit,
the issues of disclosure, stigma, and negative interactions with health workers intersected to
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create an overwhelming barrier to Option B+ participation. Women who stayed in the
PMTCT program also had fears about disclosure and stigma, but they often overcame them, in
part, through social support. Our findings point to the importance of providing or bolstering
social support for HIV-positive women with young children. Programs offering social support
can improve women’s motivation, facilitate disclosure, and reduce stigma, all of which may
contribute to their PMTCT participation [36].
The other important contribution of this study was the comparisons we made in breastfeed-
ing duration between women in the Option B+ program and those who were LTFU. Women
in our sample continued to breastfeed regardless of whether they were participating in
PMTCT. Most of the LTFU women, who never started taking ART or who stopped using it,
realized that they were putting their child at risk of HIV transmission. However, they did not
feel like they had a choice because the majority of them lived in households with regular food
insecurity and they did not have the ability to offer the child infant formula or sufficient other
foods. While food insecurity plays an important role, women’s decisions about breastfeeding
and weaning are also influenced by cultural norms. Early weaning is not appropriate in Mala-
wian culture and breastfeeding is an important part of being a mother [21,37]. Women who
wean early are assumed to have become pregnant again with a short birth interval or to be
HIV-positive, both of which have negative social consequences [38,39]. In this context, breast-
feeding norms and lack of foods that can adequately replace breastmilk override worries about
the child getting HIV through breastmilk. Programs could emphasize the importance of
women staying on ART to protect the child from transmission through breastmilk, but that
information is not sufficient without addressing the underlying issues of fear of HIV disclo-
sure, experiences of HIV stigma, and other barriers to participation.
This study had some limitations. First, one of our aims was to study duration of breastfeed-
ing among women in PMTCT and those who were LTFU. We purposely sampled women with
children in different age groups within the range from 0–23 months. This made our PMTCT
and LTFU groups comparable, but also limited our ability to document the exact timing of
weaning, since most of the women had not yet weaned their child and many planned to con-
tinue breastfeeding until 24 months. Second, we faced challenges with recruiting LTFU
women, especially in the urban clinics. The LTFU women we interviewed were open about
sharing their reasons for stopping participation, but perhaps women facing even more serious
issues, like intimate partner violence, were not included.
Conclusions
The findings of this study indicate the importance of hearing the perspectives of both PMTCT
participants and LTFU women to better understand facilitators and barriers to participation in
Option B+. Achieving higher retention rates in Option B+ will likely require efforts to scale up
evidence-based interventions that address the underlying individual, family, and facility issues
that influence participation. Efforts to increase continued PMTCT participation should
include strategies to reduce HIV stigma in health facilities and communities [40–42] and to
facilitate HIV disclosure through couple counseling and tracing and testing programs [43,44].
In-service training for health workers on maintaining confidentiality and on interacting with
patients in a positive way is needed [34]. Mechanisms for promoting social support to HIV-
positive women through their families or by building alternate supporting mechanisms (e.g.,
through HIV-positive mentor mothers) can facilitate PMTCT participation [45]. Using single
or combined intervention strategies to encourage Malawian women to stay in PMTCT may
contribute to the reduction of HIV transmission, because LTFU women are likely to continue
breastfeeding even when no longer on ART.
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